What is BioQ Pharma?
BioQ Pharma is a commercial-stage company dedicated to revolutionizing the delivery of infusible medicines. Their proprietary platform is engineered to enhance the efficacy, safety, and user-friendliness of drug administration, offering substantial value across the healthcare ecosystem, including patients, providers, and payers. The company specializes in providing bespoke, pre-filled, and adaptable delivery solutions tailored to specific dosing requirements, with a particular emphasis on challenging-to-administer infusible drugs. BioQ Pharma's patented technology is already deployed for the delivery of various infusible pharmaceuticals, aiming to streamline administration processes and bolster safety protocols.
How much funding has BioQ Pharma raised?
BioQ Pharma has raised a total of $53.7M across 5 funding rounds:
Debt
$13.7M
Private Equity
$18.3M
Debt
$15M
Private Equity
$6.3M
Debt
$350K
Debt (2014): $13.7M, investors not publicly disclosed
Private Equity (2015): $18.3M, investors not publicly disclosed
Debt (2016): $15M, investors not publicly disclosed
Private Equity (2017): $6.3M, investors not publicly disclosed
Debt (2020): $350K backed by PPP
Key Investors in BioQ Pharma
PPP
Public-Private Partnership
What's next for BioQ Pharma?
The recent major strategic investment signals a pivotal phase for BioQ Pharma, likely enabling the company to accelerate its commercialization efforts and expand the reach of its innovative drug delivery systems. This capital infusion is expected to fuel further development, enhance manufacturing capabilities, and potentially broaden its portfolio of ready-to-use connect-and-go systems. The company's focus on improving the administration of hard-to-administer infusibles positions it for significant growth in a market seeking more efficient and safer therapeutic solutions.
See full BioQ Pharma company page
